We are live on ! Find out more
FEG

Financial Enhancement Group Portfolio holdings

AUM $839M
1-Year Est. Return 18.63%
This Fund
S&P 500
This Quarter Est. Return
+1.08%
1 Year Est. Return
+18.63%
3 Year Est. Return
+57.48%
5 Year Est. Return
+65.82%
10 Year Est. Return
+209.3%
AUM
$290M
AUM Growth
+$6.74M
Cap. Flow
+$5.8M
Cap. Flow %
2%
Top 10 Hldgs %
52.55%
Holding
285
New
19
Increased
58
Reduced
49
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 7.86%
2 Financials 5.72%
3 Consumer Discretionary 3.25%
4 Energy 2.39%
5 Healthcare 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCZ icon
276
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
-14
Closed -$1K
SHOP icon
277
Shopify
SHOP
$152B
-56,500
Closed -$704K
UPLD icon
278
Upland Software
UPLD
$12.8M
-854
Closed -$246K
VBR icon
279
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
-12
Closed -$2K
VTV icon
280
Vanguard Morningstar Value ETF
VTV
$188B
-68
Closed -$7K
X
281
DELISTED
US Steel
X
$0 ﹤0.01%
6
VRTV
282
DELISTED
VERITIV CORPORATION
VRTV
$0 ﹤0.01%
2
ETFC
283
DELISTED
E*Trade Financial Corporation
ETFC
-4,351
Closed -$241K
TFCFA
284
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-10
Closed
FTR
285
DELISTED
Frontier Communications Corp.
FTR
-2
Closed

Similar funds

Financial Enhancement Group's Q2 2018 Portfolio in Review

As of Q2 2018, Financial Enhancement Group held 285 positions worth $290M, up 2.4% from $284M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Financial Enhancement Group's Q2 2018 filing shows 19 new, 58 increased, 49 reduced and 26 closed positions. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 41,400 shares worth $5.8M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $8.67M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Financial Enhancement Group's largest Q2 2018 buy was First Trust NYSE Arca Biotechnology Index Fund: 41,400 shares worth $5.8M.
  • Financial Enhancement Group added most to First Trust Enhanced Short Maturity ETF in Q2 2018, an estimated $15.5M increase.
  • Financial Enhancement Group's biggest Q2 2018 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $8.67M.
  • Financial Enhancement Group fully exited Northrop Grumman in Q2 2018, selling an estimated $6.4M.
  • Financial Enhancement Group's ten largest holdings make up 53% of its $290M portfolio in Q2 2018.
  • Financial Enhancement Group opened 19 new positions and closed 26 in Q2 2018.
  • Financial Enhancement Group's portfolio value rose 2.4% quarter-over-quarter to $290M.

Based on Financial Enhancement Group's 13F filing for Q2 2018, filed 8 Aug 2018.